alanosine and Adenocarcinoma

alanosine has been researched along with Adenocarcinoma* in 2 studies

Trials

1 trial(s) available for alanosine and Adenocarcinoma

Article	Year
Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study. Investigational new drugs, 1991, Volume: 9, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Alanine; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged	1991

Other Studies

1 other study(ies) available for alanosine and Adenocarcinoma

Article	Year
A phase II study of alanosine in advanced large bowel carcinoma. American journal of clinical oncology, 1983, Volume: 6, Issue:2 Thirty patients with advanced metastatic colorectal adenocarcinoma were treated with alanosine at a dose of 160 mg/m2 daily for 5 days every 4 weeks. Sixteen patients had received no prior chemotherapy and 14 had been previously treated with one or more cytotoxic agents. No patient met the criteria for a complete or partial response. The major toxicity was stomatitis. Topics: Adenocarcinoma; Adult; Aged; Alanine; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Rectal Neoplasms; Stomatitis	1983

Article

Year

A phase II study of alanosine in advanced large bowel carcinoma.

American journal of clinical oncology, 1983, Volume: 6, Issue:2

Thirty patients with advanced metastatic colorectal adenocarcinoma were treated with alanosine at a dose of 160 mg/m2 daily for 5 days every 4 weeks. Sixteen patients had received no prior chemotherapy and 14 had been previously treated with one or more cytotoxic agents. No patient met the criteria for a complete or partial response. The major toxicity was stomatitis.

Topics: Adenocarcinoma; Adult; Aged; Alanine; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Rectal Neoplasms; Stomatitis

1983